01 - The Problem · Deep dive

What does the cold chain actually cost?

Modern medicine is built from fragile proteins that fall apart when they get warm, so we wrap them in a global, unbroken chain of cold. Move the sliders to size the waste for a single program, then walk the chain to see where it goes.

Model one program
Spoiled in transit / year
$0
0 doses lost before a patient
Recoverable at ambient
$0
if room-temperature stability removes most spoilage

Illustrative, not a forecast. Recoverable value assumes ambient stability removes about 80% of temperature-driven spoilage.

Where it breaks

A hundred doses leave the factory. How many arrive?

Every link is a place the temperature can slip, and the failures compound down the line. Press play, or click any link to jump to it.

100 / 100 viable
0 lost to the chain so far
Factory
Hold: +2 to +8°C

Illustrative model of a refrigerated route, anchored to the WHO estimate that roughly half of vaccine doses are wasted. Per-link losses are representative, not measured.

The obvious question

So why hasn't someone just fixed it?

People have been trying for decades, and the cold chain is far better than it was. The reasons it still fails are structural, not a lack of effort.

01 - It is not a neglected problem
Solar refrigerators, insulated shippers, data loggers, and heat-sensitive vial monitors are all in service today, and most doses do arrive intact. What you are looking at is the failure rate that survives decades of sustained engineering attention.
02 - There is no single weak link to reinforce
One dose changes hands many times, and each handoff belongs to a different operator with different equipment and different incentives. Reliability multiplies down a chain, so a great many small local failures compound into one large global loss. There is no central point to strengthen.
03 - Every fix costs most where there is least
The hardest leg is the last one: a clinic at the end of an unpaved road with one refrigerator and intermittent power. It is also the leg with the thinnest budget. Every extra cold box, generator, or monitor costs the most per dose exactly where the least money exists.
04 - The monitors only watch one direction
Vial monitors change colour when a dose has been too warm. They do not react to freezing. A dose that froze against an ice pack arrives looking perfectly fine, and gets administered.

Each of these is a reason to manage the cold chain better. None of them is a reason it will stop failing.

Why it's hard

Medicine lives in a narrow window.

Most temperatures spoil a biologic. Drag the dial and watch how few actually keep it safe, and how much colder the hardest medicines demand.

+5°C
Safe · Refrigerated window
+40°C (a warm room)0°C-90°C (ultra-cold)
Refrigerated
+2 to +8°C
Most vaccines and antibody drugs. A household-fridge range, held without a lapse across thousands of miles.
Frozen
-15 to -50°C
Many mRNA vaccines. Needs freezer capacity and dry ice at every stop.
Ultra-cold
-60 to -90°C
The most fragile biologics and cell therapies. Specialized freezers only, rare outside major hubs.

Still Velocity's answer

Design the fragility out.

The cold chain exists because the medicine cannot protect itself. Still Velocity engineers new proteins that turn a fragile biologic into a stable glass at room temperature, then release it intact when water returns. No refrigeration, no chain to break. It is the trick tardigrades use to survive complete drying, redesigned on purpose for modern medicine.

See how it works →Back to stillvelocity.com

A biologic that ships at room temperature can reach any clinic, any village, any disaster zone, without refrigerated trucks or a generator that has to keep running.